Skip to main content
Journal ArticleOPEN ACCESS

Treatment Outcomes of Dolutegravir- Versus Efavirenz-Based Highly Active Antiretroviral Therapy Regimens Among Treatment-Naive People Living With HIV

  • Mahale P
  • Patel B
  • Kasmani N
Cureus (2023)
DOI: 10.7759/cureus.40139
N/ACitations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Background: In India, following the implementation of the dolutegravir (DTG) based regimen, only a few studies compared the outcomes of DTG and efavirenz (EFV) based regimens. Therefore, this study aimed to assess virological suppression and gain in CD4+ counts of DTG and EFV-based antiretroviral therapy (ART) regimens.

Cite

CITATION STYLE

APA

Mahale, P. R., Patel, B. S., & Kasmani, N. (2023). Treatment Outcomes of Dolutegravir- Versus Efavirenz-Based Highly Active Antiretroviral Therapy Regimens Among Treatment-Naive People Living With HIV. Cureus. https://doi.org/10.7759/cureus.40139

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free